Trademark search for:

RILFAVY

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2017-08-30 — Application filed
2017-11-23 — Sn assigned for sect 66a appl from ib
2017-11-30 — Application filed
2017-12-05 — Application filed
2017-12-05 — Assigned to examiner
2017-12-08 — Approved for pub - principal register
2017-12-09 — Application filed
2017-12-27 — Notice of publication
2018-01-10 — Notice of start of opposition period created, to be sent to ib
2018-01-10 — Notification of possible opposition sent to ib
2018-01-16 — Published for opposition
2018-01-27 — Notification processed by ib
2018-04-03 — Registered-principal register
2018-05-03 — Grant of protection created, to be sent to ib
2018-05-08 — Final disposition recorded
2018-05-08 — Final disposition recorded
2018-05-25 — Notification processed by ib
2024-10-18 — Cancelled section 71
2024-10-18 — Final status recorded
2025-06-18 — Total invalidation of reg ext protection created
2025-11-18 — Invalidation processed
2025-11-18 — Total invalidation of reg ext protection sent to ib
2025-12-05 — Total invalidation processed by the ib

Owner Information

NOVARTIS AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2017-08-30

Status Date:
2024-10-18

Category:
Pharmaceuticals

Filing Year:
2017

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.